Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nicotinic acetylcholine receptor variation and response to smoking cessation therapies.

Pharmacogenetics and genomics - 1 Feb 2013

Bergen Andrew W, Javitz Harold S, Krasnow Ruth, Nishita Denise, Michel Martha, Conti David V, Liu Jinghua, Lee Won, Edlund Christopher K, Hall Sharon, Kwok Pui-Yan, Benowitz Neal L, Baker Timothy B, Tyndale Rachel F, Lerman Caryn, Swan Gary E

Abstract excerpt

OBJECTIVE: To evaluate the association of nicotinic acetylcholine receptor (nAChR) single nucleotide polymorphism (SNP) with 7-day point prevalence abstinence (abstinence) in randomized clinical trials of smoking cessation therapies in individuals grouped by pharmacotherapy randomization to inform the development of personalized smoking cessation therapy. MATERIALS AND METHODS: We quantified association of four...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents, Second-Generation
Share to Benzazepines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bupropion

Share to Nicotine

Share to Nicotinic Agonists

Share to Quinoxalines

Share to Receptors, Nicotinic

Share to Smoking Cessation

Source

Open in PubMed Open full text

Identifiers

PMID: 23249876
DOI: 10.1097/FPC.0b013e32835cdabd
PMCID: PMC3563676

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nicotinic acetylcholine receptor variation and response to smoking cessation therapies.PMID 23249876Read ↗

Smoking Cessation Pharmacogenetics: Analysis of Varenicline and Bupropion in Placebo-Controlled Clinical TrialsSemantic proximity Read ↗

A systematic review of genetic variation within nicotinic acetylcholine receptor genes and cigarette smoking cessation.Semantic proximity Read ↗

Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapy.Semantic proximity Read ↗

Genetic Variant in CHRNA5 and Response to Varenicline and Combination Nicotine Replacement in a Randomized Placebo‐Controlled TrialSemantic proximity Read ↗

Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women.Semantic proximity Read ↗

Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers.Semantic proximity Read ↗

Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion.Semantic proximity Read ↗

Pharmacogenetic study of seven polymorphisms in three nicotinic acetylcholine receptor subunits in smoking-cessation therapies.Semantic proximity Read ↗

Drugs and genotypes: how pharmacogenetic information could improve smoking cessation treatment.Semantic proximity Read ↗

Genetic variation (CHRNA5), medication (combination nicotine replacement therapy vs. varenicline), and smoking cessation.Semantic proximity Read ↗

Organic cation transporter variation and response to smoking cessation therapies.Semantic proximity Read ↗

Association between nicotinic acetylcholine receptor single nucleotide polymorphisms and smoking cessation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.